연구성과로 돌아가기

2020 연구자 정보 (17 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Noureddin, Mazen
(Noureddin, M)
제1저자 Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
Panzitt, Katrin
(Panzitt, K)
제1저자 Med Univ Graz, Div Gastroenterol & Hepatol, Graz, Austria
Med Univ Graz, Res Unit Translat Nucl Receptor Res, Graz, Austria


[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Park, Jun Yong
(Park, JY)
Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea
Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
Yonsei Univ, Coll Med, Seoul, South Korea
H-7127-2019
Park, Jun
0000-0001-6324-2224
Park, Jun Yong
[JCR상위 1.6] Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea
[JCR상위 8.2] Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
[JCR상위 21.9] Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study
[JCR상위 43.6] A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy
[JCR상위 24.5] Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response
[JCR상위 4.5] Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY
ONCOLOGY;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY
GASTROENTEROLOGY & HEPATOLOGY;PHARMACOLOGY & PHARMACY
powerof1004@gmail.com;
beomkkim@yuhs.ac;psyoung0419@gmail.com;
jheo@pusan.ac.kr;ahnsh@yuhs.ac;
ihkimmd@jbnu.ac.kr;gudwns21@korea.ac.kr;KSUKOREA@yuhs.ac;
Park, Jung Gil
(Park, JG)
Yeungnam Univ, Coll Med, Internal Med, Gyongsan, South Korea
Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea
Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea
Yeungnam Univ, Coll Med, Dept Internal Med, Daegu 42415, South Korea
Yeungnam Univ, Dept Internal Med, Coll Med, Daegu 42415, South Korea
Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea
Yeungnam Univ, Dept Internal Med, Coll Med, Daegu 41944, South Korea
Daegu Gyeongbuk Liver Study Grp, Daegu, South Korea
AAK-5167-2020
Park, Jung

[JCR상위 1.6] The association with low skeletal muscle mass and carotid atherosclerosis in patients with non-alcoholic fatty liver disease
[JCR상위 1.6] Long interspersed nuclear element-1 (line-1) hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
[JCR상위 1.6] Identification of PD-L1-expressing exosome-derived microRNAs in human hepatocellular carcinoma
[JCR상위 1.6] Validation of diagnostic usefulness of the spot urine Na/K ratio for replacement of 24-hour urine NA excretion in cirrhotic patients with ascites
[JCR상위 37.2] Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
[JCR상위 28.5] Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
[JCR상위 38.0] Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
[JCR상위 7.8] Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels
[JCR상위 24.5] Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
[JCR상위 18.8] Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY
GENETICS & HEREDITY
BIOLOGY
MEDICINE, GENERAL & INTERNAL
COMPUTER SCIENCE, INFORMATION SYSTEMS;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;MATHEMATICAL & COMPUTATIONAL BIOLOGY;MEDICAL INFORMATICS
NUTRITION & DIETETICS
kmggood111@naver.com;
deblue00@naver.com;
jangha106@dsmc.or.kr;
one-many@hanmail.net;jihyunlee.knu@gmail.com;aoet111@gmail.com;eunhye7832@naver.com;deblue00@naver.com;magnolia1103@naver.com;hoongir182@naver.com;mong0101@dreamwiz.com;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;wonlee@knu.ac.kr;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung0419@gmail.com;gsnrs@naver.com;KeunHur@knu.ac.kr;
gsnrs@naver.com;med.aurora@gmail.com;magnolia1103@naver.com;deblue00@naver.com;eunhye7832@naver.com;hoongirl82@naver.com;one-many@hanmail.net;cjmdr@knu.ac.kr;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung@knu.ac.kr;keunhur@knu.ac.kr;psyoung0419@gmail.com;
psyoung0419@gmail.com;chung50@dsmc.or.kr;
dwu6@mgh.harvard.edu;kgong@mgh.harvard.edu;carru@mgh.harvard.edu;fhomayounieh@mgh.harvard.edu;bbizzo@mgh.harvard.edu;varun.buch@mgh.harvard.edu;hren2@mgh.harvard.edu;kkim24@mgh.harvard.edu;nir.neumark@mgh.harvard.edu;pxu3@mgh.harvard.edu;zliu40@mgh.harvard.edu;wfang3@mgh.harvard.edu;nxie@mgh.harvard.edu;wytak@knu.ac.kr;psy@knu.ac.kr;deblue00@naver.com;kmggood111@naver.com;jgpark@ynu.ac.kr;profcarriero@virgilio.it;lucasabamd@gmail.com;mahsami141@gmail.com;rosa.babaei@gmail.com;hadi.karimimobin@gmail.com;sebrahimian@mgh.harvard.edu;idayan@partners.org;mkalra@mgh.harvard.edu;quanzheng@mgh.harvard.edu;
chung50@dsmc.or.kr;kbs9225@cu.ac.kr;psyoung0419@gmail.com;
gsnrs@naver.com;wytak@knu.ac.kr;psyoung0419@gmail.com;yokweon@knu.ac.kr;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;baesh@catholic.ac.kr;hjlee@med.yu.ac.kr;jyjang@hosp.sch.ac.kr;ktsuk@hallym.ac.kr;zenus1@hanmail.net;jheo@pusan.ac.kr;who54@hanmail.net;magnolia1103@naver.com;deblue00@naver.com;jsleemd@paik.ac.kr;dyk1025@yuhs.ac;midoctor@cnu.ac.kr;sujungil@dongguk.ac.kr;ihkimmd@chonbuk.ac.kr;kmggood111@naver.com;wonlee@knu.ac.kr;
Park, Soo Young
(Park, SY)
Kyungpook Natl Univ, Sch Med, Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Sch Med, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea
Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Dept Internal Med, Coll Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu 41944, South Korea
Daegu Gyeongbuk Liver Study Grp, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Daegu, South Korea
N-3170-2017
park, soo-young
0000-0002-4944-4396
0000-0001-6796-4929
Park, Soo Young
park, soo-young
[JCR상위 1.6] The association with low skeletal muscle mass and carotid atherosclerosis in patients with non-alcoholic fatty liver disease
[JCR상위 38.6] Treatment Outcomes and Prognostic Factors of Acute variceal Bleeding in Patients with Hepatocellular Carcinoma
Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation
[JCR상위 1.6] Long interspersed nuclear element-1 (line-1) hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
[JCR상위 1.6] Identification of PD-L1-expressing exosome-derived microRNAs in human hepatocellular carcinoma
[JCR상위 6.0] CHANGES OF HBsAg QUANTITY AND ITS RELATION WITH HBEAG SEROCONVERSION FOLLOWING 48 WEEKS PEGYLATED-INTERFERON-ALPHA TREATMENT IN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B AFTER LONG TERM NUCLEOS(T)IDE ANALOGUE MAINTENANCE THERAPY; ROLL OVER TRIAL
[JCR상위 1.6] Validation of diagnostic usefulness of the spot urine Na/K ratio for replacement of 24-hour urine NA excretion in cirrhotic patients with ascites
[JCR상위 54.8] Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
[JCR상위 37.2] Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
[JCR상위 8.2] Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
[JCR상위 28.5] Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
[JCR상위 21.9] Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study
[JCR상위 38.0] Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
[JCR상위 43.6] A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy
[JCR상위 7.8] Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels
[JCR상위 24.5] Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
[JCR상위 4.5] Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
[JCR상위 43.6] Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
[JCR상위 18.8] Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
[JCR상위 6.0] REVISITING THE IMPACT OF HBEAG-STATUS OF ANTIVIRAL TREATMENT ON RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT: A NATIONWIDE MULTICENTER STUDY
[JCR상위 6.0] APCOLIS SCORE PREDICTS OUTCOME IN PATIENTS OF CIRRHOSIS WITH SARS-COV-2 INFECTION- DATA FROM ONGOING APASL COVID LIVER INJURY SPECTRUM (APCOLIS-I) STUDY
SCIE
ESCI
1.6 GASTROENTEROLOGY & HEPATOLOGY
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
MEDICINE, GENERAL & INTERNAL
GENETICS & HEREDITY
BIOLOGY
ONCOLOGY;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY
COMPUTER SCIENCE, INFORMATION SYSTEMS;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;MATHEMATICAL & COMPUTATIONAL BIOLOGY;MEDICAL INFORMATICS
GASTROENTEROLOGY & HEPATOLOGY;PHARMACOLOGY & PHARMACY
NUTRITION & DIETETICS
kmggood111@naver.com;
psyoung0419@gmail.com;wytak@knu.ac.kr;
specialwent@naver.com;lsyrad@gmail.com;hkryeom@knu.ac.kr;blushain@gmail.com;wytak@knu.ac.kr;magnolia1103@naver.com;yokweon@knu.ac.kr;psyoung0419@gmail.com;deblue00@naver.com;
deblue00@naver.com;
jangha106@dsmc.or.kr;
chung50@dsmc.or.kr;
one-many@hanmail.net;jihyunlee.knu@gmail.com;aoet111@gmail.com;eunhye7832@naver.com;deblue00@naver.com;magnolia1103@naver.com;hoongir182@naver.com;mong0101@dreamwiz.com;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;wonlee@knu.ac.kr;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung0419@gmail.com;gsnrs@naver.com;KeunHur@knu.ac.kr;
beomkkim@yuhs.ac;psyoung0419@gmail.com;
gsnrs@naver.com;med.aurora@gmail.com;magnolia1103@naver.com;deblue00@naver.com;eunhye7832@naver.com;hoongirl82@naver.com;one-many@hanmail.net;cjmdr@knu.ac.kr;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung@knu.ac.kr;keunhur@knu.ac.kr;psyoung0419@gmail.com;
psyoung0419@gmail.com;chung50@dsmc.or.kr;
dwu6@mgh.harvard.edu;kgong@mgh.harvard.edu;carru@mgh.harvard.edu;fhomayounieh@mgh.harvard.edu;bbizzo@mgh.harvard.edu;varun.buch@mgh.harvard.edu;hren2@mgh.harvard.edu;kkim24@mgh.harvard.edu;nir.neumark@mgh.harvard.edu;pxu3@mgh.harvard.edu;zliu40@mgh.harvard.edu;wfang3@mgh.harvard.edu;nxie@mgh.harvard.edu;wytak@knu.ac.kr;psy@knu.ac.kr;deblue00@naver.com;kmggood111@naver.com;jgpark@ynu.ac.kr;profcarriero@virgilio.it;lucasabamd@gmail.com;mahsami141@gmail.com;rosa.babaei@gmail.com;hadi.karimimobin@gmail.com;sebrahimian@mgh.harvard.edu;idayan@partners.org;mkalra@mgh.harvard.edu;quanzheng@mgh.harvard.edu;
chung50@dsmc.or.kr;kbs9225@cu.ac.kr;psyoung0419@gmail.com;
ihkimmd@jbnu.ac.kr;gudwns21@korea.ac.kr;KSUKOREA@yuhs.ac;
gie001@cnuh.co.kr;ksukorea@yuhs.ac;
gsnrs@naver.com;wytak@knu.ac.kr;psyoung0419@gmail.com;yokweon@knu.ac.kr;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;baesh@catholic.ac.kr;hjlee@med.yu.ac.kr;jyjang@hosp.sch.ac.kr;ktsuk@hallym.ac.kr;zenus1@hanmail.net;jheo@pusan.ac.kr;who54@hanmail.net;magnolia1103@naver.com;deblue00@naver.com;jsleemd@paik.ac.kr;dyk1025@yuhs.ac;midoctor@cnu.ac.kr;sujungil@dongguk.ac.kr;ihkimmd@chonbuk.ac.kr;kmggood111@naver.com;wonlee@knu.ac.kr;
Park, Sung-Jae
(Park, SJ)
Inje Univ, Busan Paik Hosp, Busan, South Korea

[JCR상위 1.6] Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY jkwoh@ionisph.com;
Pollheimer, Marion
(Pollheimer, M)
Med Univ Graz, Inst Pathol, Graz, Austria

[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Rinella, Mary
(Rinella, M)
Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA AAJ-4065-2021
rinella, mary

[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
Sarin, Shiv Kumar
(Sarin, SK)
Inst Liver & Biliary Sci, New Delhi, India
Inst Liver & Biliary Sci, Dept Hepatol & Liver Transplant, New Delhi 110070, India
Inst Liver & Biliary Sci, Hepatol, New Delhi, India


[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials
[JCR상위 25.5] Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
[JCR상위 6.0] APCOLIS SCORE PREDICTS OUTCOME IN PATIENTS OF CIRRHOSIS WITH SARS-COV-2 INFECTION- DATA FROM ONGOING APASL COVID LIVER INJURY SPECTRUM (APCOLIS-I) STUDY
SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
shivsarin@gmail.com;
Schattenberg, Joern M.
(Schattenberg, JM)
Univ Med Ctr Mainz, Dept Med 1, Metab Liver Res Program, Mainz, Germany C-1301-2013
Schattenberg, Jörn

[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
Seo, Jae Kyoung
(Seo, JK)
Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Daegu, South Korea

[JCR상위 1.6] Identification of PD-L1-expressing exosome-derived microRNAs in human hepatocellular carcinoma SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY deblue00@naver.com;
Shankar, Arun
(Shankar, A)
Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England C-4779-2009
Shanker, Arun

[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
Song, Jung Eun
(Song, JE)


[JCR상위 1.6] Validation of diagnostic usefulness of the spot urine Na/K ratio for replacement of 24-hour urine NA excretion in cirrhotic patients with ascites SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY jangha106@dsmc.or.kr;
Subramanian, Mani
(Subramanian, M)
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[JCR상위 1.6] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY pietro.lampertico@unimi.it;
Suh, Jeong Ill
(Suh, JI)
Dongguk Univ, Dept Internal Med, Coll Med, Gyeongju, South Korea
Dongguk Univ, Gyeongju Hosp, Coll Med, Dept Internal Med, Gyeongju, South Korea
Daegu Gyeongbuk Liver Study Grp, Daegu, South Korea
Dongguk Univ, Coll Med, Dept Internal Med, Gyeongju 39067, South Korea
Dongguk Univ, Dept Internal Med, Gyeongju Hosp, Gyeongju, South Korea


[JCR상위 1.6] Validation of diagnostic usefulness of the spot urine Na/K ratio for replacement of 24-hour urine NA excretion in cirrhotic patients with ascites
[JCR상위 54.8] Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
[JCR상위 38.0] Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
[JCR상위 24.5] Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
[JCR상위 18.8] Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
[JCR상위 25.5] Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, GENERAL & INTERNAL
NUTRITION & DIETETICS
jangha106@dsmc.or.kr;
chung50@dsmc.or.kr;
psyoung0419@gmail.com;chung50@dsmc.or.kr;
chung50@dsmc.or.kr;kbs9225@cu.ac.kr;psyoung0419@gmail.com;
gsnrs@naver.com;wytak@knu.ac.kr;psyoung0419@gmail.com;yokweon@knu.ac.kr;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;baesh@catholic.ac.kr;hjlee@med.yu.ac.kr;jyjang@hosp.sch.ac.kr;ktsuk@hallym.ac.kr;zenus1@hanmail.net;jheo@pusan.ac.kr;who54@hanmail.net;magnolia1103@naver.com;deblue00@naver.com;jsleemd@paik.ac.kr;dyk1025@yuhs.ac;midoctor@cnu.ac.kr;sujungil@dongguk.ac.kr;ihkimmd@chonbuk.ac.kr;kmggood111@naver.com;wonlee@knu.ac.kr;
shivsarin@gmail.com;
페이지 이동: